Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant

Vanessa A. Fabrizio, Nancy A. Kernan, Farid Boulad, Maria Cancio, Jennifer D. Allen, Meghan A. Higman, Steven Margossian, Audrey Mauguen, Susan E. Prockop, Andromachi Scaradavou, Niketa C. Shah, Barbara Spitzer, Elliot Stieglitz, Nicholas D. Yeager, Richard J. O’Reilly, Renier J. Brentjens, Jaap Jan Boelens, Kevin J. Curran